Abstract
Background The health care workers (HCWs) were one of the vulnerable populations prioritized during the Covid-19 vaccination (COVISHIELD and COVAXIN) campaign. They are also the first point of contact for vaccine-related information and therefore, play a crucial role in shaping peoples’ vaccine seeking behaviour.
Objectives (i) To estimate the proportion of Covid-19 vaccine hesitancy among HCWs in urban primary health care centres (UPHC) across Hyderabad; and (ii) To explore factors influencing vaccine hesitancy and vaccine acceptance in this population.
Methods A cross-sectional study was conducted among 238 HCWs from 21 urban health centres in Hyderabad between June and July 2021. The prevalence of vaccine hesitancy was assessed using the questions adapted from ‘the UNICEF Guyana Covid-19 Vaccination Hesitancy Survey’. We used ‘the SAGE determinants of vaccine hesitancy’ to determine factors underlying vaccine hesitancy and acceptance.
Results The prevalence of vaccine hesitancy among HCWs was 17% (12.3% - 22.2%) during the 6 months following emergency vaccine approval. ‘Self-protection’, ‘Vaccine-confidence’, and ‘Responsibility towards the general population’ were some of the reasons in favour of Covid-19 vaccination. Whereas ‘Vaccine-safety’ has emerged as the primary determinant of vaccine-hesitancy in this population. HCWs were susceptible to misinformation in the social media and in their communities, which might have shaped their opinion about the vaccines for the Covid-19.
Conclusion Although the COVID-19 vaccines (COVISHIELD and COVAXIN) were approved for administration by the Drugs Controller General of India, one in every six HCWs working in the UPHCs in Hyderabad, India had either refused or delayed vaccinations mainly due to limited information on ‘vaccine-safety’. This highlights a critical need to address the vaccine-hesitancy among HCWs (especially during the initial phases of novel vaccine introduction), as similar behaviour of the HCWs towards novel vaccines could affect the uptake of these vaccines among the general population (which they serve).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Indian Institute of Public Health, Hyderabad, India gave ethical approval for this work. Approval no. & Date: IIPHH/TRCIEC/264/2020; Dated: 28/06/2021
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data cannot be shared publicly because of Data privacy policies of Indian Institute of Public Health, Hyderabad, India. The Data are available from the Indian Institute of Public Health, Hyderabad from the Institutional Data Access / Ethics Committee; contact via email to Dr Nanda Kishore Kannuri nandu.k{at}iiphh.org for researchers who meet the criteria for access to confidential data.
